HAP Trading’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,777
| Closed | -$3.01M | – | 837 |
|
|
2025
Q2 | $2.74M | Buy |
+14,777
| New | +$2.75M | 0.26% | 63 |
|
|
2024
Q1 | – | Sell |
-20,530
| Closed | -$3.18M | – | 690 |
|
|
2023
Q4 | $3.18M | Buy |
20,530
+2,340
| +13% | +$341K | 0.51% | 48 |
|
|
2023
Q3 | $2.71M | Sell |
18,190
-3,801
| -17% | -$558K | 0.43% | 53 |
|
|
2023
Q2 | $2.96M | Sell |
21,991
-27,243
| -55% | -$3.99M | 0.52% | 37 |
|
|
2023
Q1 | $7.85M | Buy |
+49,234
| New | +$7.53M | 1.23% | 14 |
|
|
2022
Q4 | – | Sell |
-10,882
| Closed | -$1.67M | – | 1468 |
|
|
2022
Q3 | $1.46M | Buy |
+10,882
| New | +$1.56M | 0.1% | 192 |
|
|
2021
Q3 | – | Sell |
-15,380
| Closed | -$1.76M | – | 2389 |
|
|
2021
Q2 | $1.73M | Sell |
15,380
-39,690
| -72% | -$4.47M | 0.05% | 321 |
|
|
2021
Q1 | $5.96M | Buy |
55,070
+21,824
| +66% | +$2.33M | 0.32% | 58 |
|
|
2020
Q4 | $3.56M | Buy |
33,246
+3,501
| +12% | +$336K | 0.1% | 170 |
|
|
2020
Q3 | $2.6M | Buy |
29,745
+13,112
| +79% | +$1.23M | 0.13% | 129 |
|
|
2020
Q2 | $1.63M | Sell |
16,633
-7,692
| -32% | -$677K | 0.09% | 197 |
|
|
2020
Q1 | $1.85M | Buy |
24,325
+9,611
| +65% | +$819K | 0.12% | 134 |
|
|
2019
Q4 | $1.3M | Buy |
+14,714
| New | +$1.22M | 0.07% | 166 |
|
|
2019
Q3 | – | Sell |
-26,248
| Closed | -$1.8M | – | 1213 |
|
|
2019
Q2 | $1.91M | Buy |
26,248
+8,056
| +44% | +$633K | 0.15% | 121 |
|
|
2019
Q1 | $1.47M | Buy |
18,192
+7,499
| +70% | +$613K | 0.13% | 141 |
|
|
2018
Q4 | $986K | Buy |
+10,693
| New | +$940K | 0.06% | 236 |
|
|
2017
Q2 | – | Sell |
-14,270
| Closed | -$959K | – | 924 |
|
|
2017
Q1 | $930K | Buy |
+14,270
| New | +$897K | 0.06% | 242 |
|
|
2015
Q4 | – | Sell |
-12,693
| Closed | -$731K | – | 939 |
|
|
2015
Q3 | $691K | Sell |
12,693
-8,230
| -39% | -$536K | 0.04% | 325 |
|
|
2015
Q2 | $1.41M | Sell |
20,923
-38,415
| -65% | -$2.51M | 0.08% | 217 |
|
|
2015
Q1 | $3.47M | Buy |
+59,338
| New | +$3.58M | 0.23% | 93 |
|
|
2014
Q4 | – | Sell |
-42,475
| Closed | -$2.68M | – | 1028 |
|
|
2014
Q3 | $2.45M | Sell |
42,475
-143,700
| -77% | -$7.98M | 0.1% | 172 |
|
|
2014
Q2 | $10.5M | Buy |
+186,175
| New | +$9.77M | 0.39% | 45 |
|
|
2013
Q4 | – | Sell |
-89,717
| Closed | -$4.41M | – | 1206 |
|
|
2013
Q3 | $4.01M | Sell |
89,717
-326,531
| -78% | -$14.5M | 0.13% | 139 |
|
|
2013
Q2 | $17.2M | Buy |
+416,248
| New | +$18.2M | 0.58% | 32 |
|
Other funds holding ABBV
HAP Trading's ABBV Position: Q3 2025 in Review
HAP Trading sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 14,777 shares — an estimated $3.01M sold.
HAP Trading first reported a position in ABBV in Q2 2013 and held it in 24 quarters. The position peaked at $17.2M in Q2 2013. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- HAP Trading reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- HAP Trading sold 14,777 AbbVie shares in Q3 2025, an estimated $3.01M.
- HAP Trading first reported a position in AbbVie in Q2 2013 and held it in 24 quarters.
- HAP Trading's AbbVie position peaked at $17.2M in Q2 2013.
- 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.